Neurologix
Innovative therapies for brain and neurological disorders with a focus on gene therapy treatments for conditions like Parkinson's disease and epilepsy.
General Information
BounceWatch is an independent company data service, not affiliated with Neurologix. To contact Neurologix, visit neurologix.net.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Neurologix compare?
A PDF of Neurologix and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Neurologix soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Neurologix
Business keywords: neurological disorders, gene therapy, Parkinson's disease, epilepsy, neurodegenerative disorders, central nervous system, therapeutic treatments, gene transfers, Huntington's disease, depression, metabolic disorders, Fort Lee, New Jersey, brain disorders, development stage company
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $7.00M | 3 |
Palisade Capital Management, Corriente Advisors +1
|
06 Dec 2010 |
Neurologix Alternatives & Competitors
View All Alternatives
A clinical stage pharmaceutical company developing innovative treatments for neurological disease.
Transforming how we treat Alzheimer’s, Parkinson’s, and beyond.
FAQ About Neurologix
Source: BounceWatch company record for Neurologix, https://bouncewatch.com/company/neurologix, updated 27 December 2024. When citing, please name BounceWatch and link this page.
